Search Results - "Vassalotti, J. A."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Surveillance of CKD epidemiology in the US – a joint analysis of NHANES and KEEP by Myers, O. B., Pankratz, V. S., Norris, K. C., Vassalotti, J. A., Unruh, M. L., Argyropoulos, C.

    Published in Scientific reports (26-10-2018)
    “…Chronic Kidney Disease (CKD), is highly prevalent in the United States. Epidemiological systems for surveillance of CKD rely on data that are based solely on…”
    Get full text
    Journal Article
  2. 2

    Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping by Vassalotti, J A, Falk, A, Cohl, E D, Uribarri, J, Teodorescu, V

    Published in Clinical nephrology (01-09-2002)
    “…The arteriovenous fistula (AVF) is the preferred hemodialysis access. Subset analyses of both the HEMO and DOPPS studies have shown that obese hemodialysis…”
    Get more information
    Journal Article
  3. 3

    Efficacy of reteplase in poorly functioning hemodialysis catheters by Falk, A, Samson, W, Uribarri, J, Vassalotti, J A

    Published in Clinical nephrology (01-01-2004)
    “…This is a retrospective study of reteplase efficacy for restoration of flow in occluded and poorly functioning hemodialysis catheters. From May 1, 2001 to…”
    Get more information
    Journal Article
  4. 4

    Treatment of "swing point stenoses" in hemodialysis arteriovenous fistulae by Falk, A, Teodorescu, V, Lou, W Y W, Uribarri, J, Vassalotti, J A

    Published in Clinical nephrology (01-07-2003)
    “…This is a retrospective study of percutaneous transluminal balloon angioplasty (PTA) efficacy for treatment of surgical vein mobilization site ("swing point")…”
    Get more information
    Journal Article
  5. 5

    Hemodialysis access placement with preoperative noninvasive vascular mapping: Comparison between patients with and without diabetes by Sedlacek, Martin, Teodorescu, Victoria, Falk, Abigail, Vassalotti, Joseph A., Uribarri, Jaime

    Published in American journal of kidney diseases (01-09-2001)
    “…We retrospectively analyzed data on preoperative vascular mapping in 195 consecutive patients to investigate the common belief that patients with diabetes are…”
    Get full text
    Journal Article
  6. 6

    Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program by McCullough, P. A., Whaley-Connell, A., Brown, W. W., Collins, A. J., Chen, S.-C., Li, S., Norris, K. C., Jurkovitz, C., McFarlane, S., Obialo, C., Sowers, J., Stevens, L., Vassalotti, J. A., Bakris, G. L.

    Published in Internal medicine journal (01-12-2010)
    “…Background: Coronary artery disease (CAD) identifies the need for intensive treatment of risk factors among individuals with chronic kidney disease (CKD), a…”
    Get full text
    Journal Article
  7. 7

    Drug use concomitant with cyclosporine immunosuppressive therapy for 3 years after renal transplantation by Thamer, M, Chan, JK, Ray, NF, Vassalotti, JA, Kimmel, PL

    Published in American journal of kidney diseases (01-02-1998)
    “…Little is known about outpatient drug use concomitant with cyclosporine immunosuppressive therapy following renal transplantation. In part, this stems from the…”
    Get full text
    Journal Article
  8. 8

    Vascular screening prior to placement of tunnelled and cuffed hemodialysis catheters by Falk, A, Lookstein, R, Uribarri, J, Shen, C, Teodorescu, V, Vassalotti, J A

    Published in The journal of vascular access (01-10-2002)
    “…To demonstrate the importance of venous vascular screening before the placement of tunneled and cuffed hemodialysis catheters in patients requiring…”
    Get full text
    Journal Article
  9. 9

    Treatment of human immunodeficiency virus (HIV)-associated nephropathy by Kimmel, P L, Bosch, J P, Vassalotti, J A

    Published in Seminars in nephrology (01-07-1998)
    “…Patients with human immunodeficiency virus (HIV) nephropathy (HIVN) face improved outlooks both before and after starting renal replacement therapy for…”
    Get more information
    Journal Article
  10. 10

    Testing for Chronic Kidney Disease: A Position Statement From the National Kidney Foundation by Vassalotti, Joseph A., MD, Stevens, Lesley A., MD, MS, Levey, Andrew S., MD

    Published in American journal of kidney diseases (01-08-2007)
    “…Chronic kidney disease (CKD) is common in the United States. The estimated prevalence of CKD in US adults was 11.7% ± 0.8% in 2000, based on the National…”
    Get full text
    Journal Article
  11. 11

    Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients by Uribarri, Jaime, Peppa, Melpomeni, Cai, Wejing, Goldberg, Teresia, Lu, Min, Baliga, Suresh, Vassalotti, Joseph A, Vlassara, Helen

    Published in American journal of kidney diseases (01-09-2003)
    “…Background: Levels of advanced glycation end products (AGEs), well-known proinflammatory compounds, are markedly elevated in patients with renal failure,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The New Arteriovenous Fistula: The Need for Earlier Evaluation and Intervention by Kian, Kaveh, Vassalotti, Joseph A.

    Published in Seminars in dialysis (01-01-2005)
    “…ABSTRACT The National Kidney Foundation's Dialysis Outcomes Quality Initiative recommends an ideal 3‐ to 4‐month arteriovenous fistula (AVF) maturation period…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The multidisciplinary approach to hemodialysis vascular access at the Mount Sinai Hospital by Vassalotti, Joseph A, Falk, Abigail, Teodorescu, Victoria, Uribarri, Jaime

    Published in The Mount Sinai journal of medicine (01-03-2004)
    “…A majority of the quarter of a million end-stage renal disease patients nationwide are treated with hemodialysis. Important and frequent causes of morbidity…”
    Get more information
    Journal Article
  16. 16